Arecor Therapeutics and TRx Biosciences collaboration for oral diabetes treatment
LONDON: Arecor Therapeutics plc and TRx Biosciences Limited have entered into a research collaboration to develop an oral form of glucagon-like peptide-1 (GLP-1) receptor agonist, a treatment for type 2 diabetes and obesity. The partnership aims to overcome the challenges…